These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24329736)

  • 1. Association of soluble receptor for advanced glycation end products levels with hypertensive albuminuria.
    Zheng H; Yuan L; Xie N; Xu H; Xie X; Luo M
    Curr Vasc Pharmacol; 2015; 13(2):259-64. PubMed ID: 24329736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ratio of AGE to sRAGE independently associated with albuminuria in hypertensive patients.
    Chiang KH; Chen JW; Huang SS; Leu HB; Lin SJ; Huang PH
    BMC Endocr Disord; 2018 Nov; 18(1):84. PubMed ID: 30424768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble receptor for advanced glycation end-product levels are related to albuminuria and arterial stiffness in essential hypertension.
    Dimitriadis K; Tsioufis C; Kasiakogias A; Miliou A; Poulakis M; Kintis K; Bafakis I; Benardis E; Tousoulis D; Stefanadis C
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):382-8. PubMed ID: 22212601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. sRAGE and early signs of cardiac target organ damage in mild hypertensives.
    Maresca AM; Guasti L; Bozzini S; Mongiardi C; Tandurella N; Corso R; Zerba FG; Squizzato A; Campiotti L; Dentali F; Klersy C; Grandi AM; Falcone C
    Cardiovasc Diabetol; 2019 Feb; 18(1):17. PubMed ID: 30755202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum bilirubin levels with albuminuria in patients with essential hypertension.
    Huang SS; Huang PH; Chiang KH; Chen JW; Lin SJ
    Clin Biochem; 2011 Jul; 44(10-11):859-63. PubMed ID: 21515250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria.
    Huang PH; Huang SS; Chen YH; Lin CP; Chiang KH; Chen JS; Tsai HY; Lin FY; Chen JW; Lin SJ
    J Hypertens; 2010 Aug; 28(8):1655-65. PubMed ID: 20520578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension.
    Diekmann F; Chouvarine P; Sallmon H; Meyer-Kobbe L; Kieslich M; Plouffe BD; Murthy SK; Lichtinghagen R; Legchenko E; Hansmann G
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.
    Gryszczyńska B; Budzyń M; Begier-Krasińska B; Osińska A; Boruczkowski M; Kaczmarek M; Bukowska A; Iskra M; Kasprzak MP
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
    Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end-products in patients without pre-existing lung injury.
    Jabaudon M; Futier E; Roszyk L; Sapin V; Pereira B; Constantin JM
    Respirology; 2015 Oct; 20(7):1131-8. PubMed ID: 26122046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients.
    Jafari Nakhjavani MR; Jafarpour M; Ghorbanihaghjo A; Abedi Azar S; Malek Mahdavi A
    Mod Rheumatol; 2019 Nov; 29(6):943-948. PubMed ID: 30474471
    [No Abstract]   [Full Text] [Related]  

  • 12. Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.
    Falcone C; Buzzi MP; Bozzini S; Boiocchi C; D'Angelo A; Schirinzi S; Esposito C; Torreggiani M; Choi J; Ochan Kilama M; Mancia G
    Mediators Inflamm; 2012; 2012():874149. PubMed ID: 22474401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Possible Impact of Hyperuricemia on Serum Soluble Receptor for Advanced Glycation end Products (sRAGE) Levels in Teenagers: A Case Control Study.
    Lemiesz M; Tenderenda-Banasiuk E; Sosnowska D; Rybi-Szumińska A; Storonowicz J; Lemiesz T; Wasilewska A
    Curr Pharm Des; 2018; 24(27):3232-3239. PubMed ID: 30101695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension.
    Geroldi D; Falcone C; Emanuele E; D'Angelo A; Calcagnino M; Buzzi MP; Scioli GA; Fogari R
    J Hypertens; 2005 Sep; 23(9):1725-9. PubMed ID: 16093918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study.
    Laudenslager M; Lazo M; Wang D; Selvin E; Chen PH; Pankow JS; Clark JM
    Dig Liver Dis; 2021 Jul; 53(7):873-878. PubMed ID: 33640303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship between the Soluble Receptor for Advanced Glycation End Products and Oxidative Stress in Patients with Palmoplantar Warts.
    Mitran CI; Nicolae I; Tampa M; Mitran MI; Caruntu C; Sarbu MI; Ene CD; Matei C; Ionescu AC; Georgescu SR; Popa MI
    Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31635193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes.
    Pena MJ; Jankowski J; Heinze G; Kohl M; Heinzel A; Bakker SJ; Gansevoort RT; Rossing P; de Zeeuw D; Heerspink HJ; Jankowski V
    J Hypertens; 2015 Oct; 33(10):2123-32. PubMed ID: 26237555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble form of receptor for advanced glycation end products and incidence of new cardiovascular events among patients with cardiovascular disease.
    Reichert S; Triebert U; Santos AN; Hofmann B; Schaller HG; Schlitt A; Schulz S
    Atherosclerosis; 2017 Nov; 266():234-239. PubMed ID: 28864204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of soluble Receptor for Advanced Glycation End-products (RAGE) are associated with a higher risk of mortality in frail older adults.
    Butcher L; Carnicero JA; Gomez Cabrero D; Dartigues JF; Pérès K; Garcia-Garcia FJ; Rodriguez-Mañas L; Erusalimsky JD;
    Age Ageing; 2019 Sep; 48(5):696-702. PubMed ID: 31211360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble receptor for advanced glycation end products in late-onset neonatal infection.
    Zolakova B; Zolak V; Hatok J; Matasova K; Nosal S; Zibolen M
    Bratisl Lek Listy; 2016; 117(1):15-8. PubMed ID: 26810163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.